Oxaprozin

奥沙普秦

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameOxaprozin
Drug Alias Name噁丙嗪片oxaprozinaoxaprozine奥沙普嗪恶丙嗪 +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsPostoperative inflammationPainPeriarthritis +[9] 
Global Approved IndicationsPostoperative inflammationPainPeriarthritis +[9] 
Approved Indications in ChinaPostoperative inflammationPainPeriarthritis +[8] 
Original Approved Country/TerritoryUnited States
Original Approved Date1992/10/29
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPfizer Inc
China Registration ClassN/A

Develop Information

Active CompaniesPfizer IncSunflower Pharmaceutical Group Jiamusi Luling Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsPostoperative inflammationPainPeriarthritis +[9] 
Inactive IndicationsN/A

Other Information

ATC CodeM01AE12
Related LinksWikipediaDrugBankKEGG